1 / 3

Amyotrophic Lateral Sclerosis Market Insights and Epidemiology Forecast

Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is a group of rare neurological diseases that mainly involve the nerve cells (neurons), responsible for controlling voluntary muscle movement.

xmichael
Download Presentation

Amyotrophic Lateral Sclerosis Market Insights and Epidemiology Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is a group of rare neurological diseases that mainly involve the nerve cells (neurons), responsible for controlling voluntary muscle movement. Voluntary muscles produce movements like chewing, walking, and talking. The disease is progressive, meaning the symptoms get worse over time. ALS belongs to a broader group of disorders known as motor neuron diseases, which are caused by gradual deterioration and death of motor neurons. Amyotrophic Lateral Sclerosis Epidemiology Segmentation in the 7MM ● ● ● ● ● ● ● Prevalent Population of Amyotrophic Lateral Sclerosis Diagnosed Prevalent Population of Amyotrophic Lateral Sclerosis Gender-Specific Distribution of Amyotrophic Lateral Sclerosis Mutation-Specific Distribution of Amyotrophic Lateral Sclerosis Type-specific Distribution of Amyotrophic Lateral Sclerosis Site of Onset of Amyotrophic Lateral Sclerosis Age-specific Distribution of Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis Epidemiological Insights Observed in the 7MM in 2021 (2020) ● The total diagnosed prevalent cases of Amyotrophic Lateral Sclerosis in the 7MM were found to be 52k in the year 2021. The total diagnosed prevalent cases of Amyotrophic Lateral Sclerosis in the US were observed to be 20.5k cases in the year 2021. The total diagnosed prevalent cases of Amyotrophic Lateral Sclerosis in Germany were found to be 5k in the year 2021, while they were found to be 4k in Italy, and in Spain, they were observed to be 3k cases. The total diagnosed prevalent cases of Amyotrophic Lateral Sclerosis in Japan were estimated to be 10.7k cases in 2021. ● ● ● Amyotrophic Lateral Sclerosis Market Insight The market size of Amyotrophic Lateral Sclerosis in the 7MM was found to be approximately USD 460 million in 2020. Amyotrophic Lateral Sclerosis Market Drivers ● ● ● Availability of Epidemiological Data Robust Pipeline Activity Increasing Awareness Programs Amyotrophic Lateral Sclerosis Market Barriers ● ● High Medical Cost Lack of Proper Diagnosis

  2. ● ● High Mortality Rate No cure, only delaying progression Amyotrophic Lateral Sclerosis Emerging Therapies The emerging drugs in the Amyotrophic Lateral Sclerosis market are ● ● ● ● ● ● ● ● ● ● Tofersen (BIIB067) ION363 Ibudilast Masitinib AMX0035 EPI-589 Verdiperstat Zilucoplan AT-1501 RNS60, and many others Amyotrophic Lateral Sclerosis Key Players The key players working in the Amyotrophic Lateral Sclerosis market are ● ● ● ● ● ● ● ● ● ● Ionis Pharmaceuticals MediciNova Amylyx Pharmaceuticals Seelos Therapeutics Prilenia Therapeutics Biohaven Pharmaceuticals Apellis Pharmaceuticals Eledon Pharmaceuticals NeuroSense Therapeutics Biogen, and many more

More Related